Each tablet contains Montelukast 10 mg and Levocetirizine 5 mg.

Dual-action anti-allergic formulation combining leukotriene receptor antagonist and antihistaminic activities for effective management of allergic rhinitis. Provides relief from sneezing, rhinorrhea, nasal congestion, and associated allergic symptoms.

Indicated for the treatment of allergic rhinitis.

Montelukast inhibits the physiologic actions of leukotriene LTD4 at CysLT1 receptors, thereby reducing airway inflammation and allergic responses associated with allergic rhinitis. Levocetirizine, the active R-enantiomer of cetirizine, is a potent and selective peripheral H1-receptor antagonist that relieves histamine-mediated allergic symptoms.

Adults above 15 years: One tablet once daily or as directed by the physician.

Contraindicated in patients with known hypersensitivity to montelukast, levocetirizine, cetirizine, or any component of the formulation.